Sutro Biopharma, Inc. (STRO) dividend history

STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30

$10.26+0.09 (+0.88%)

Close on Nov 11, 2026Market cap $170.12MP/E –Yield –

Dividends

No dividend per share appears in Sutro Biopharma's annual filings since fiscal 2015.

Parsed from the XBRL in Sutro Biopharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Dec 3, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STRO.

Revenue growth-56.3% · median 25.8%

Operating margin-319.6% · median -295.9%

Net margin-395.2% · median -267.8%

Advertisement
300 × 250

See a number that looks wrong?